Element Science, GSR Ventures, MDLIVE at Future of Virtual Care

Steven Loeb · June 18, 2020 · Short URL: https://vator.tv/n/5063

Executives and investors to discuss how we're ramping up virtual care

On July 1, Vator, along with HP, will be holding the Future of Virtual Care event as part of the  Invent Health series.

The #inventhealth salons are quarterly "intimate" events hosted by VatorHP and UCSF Health Hub, where the audience (100-200) and select speakers interact around one topic. Topics have included "Mental Health", "Reinventing the doctor's role", "Future of clinics", "Lifestyle", etc and are discussed by influencers from various backgrounds to provide a 360-degree perspective. The goal is to create an environment conducive to creating connections amongst guests and to have a solid discussion and/or debate around one area of healthcare that's ripe for innovation. 

The topic this quarter is: “The Future of Virtual Care.” We live in a data-rich world in which technology is gathering huge swaths of population data including our own unique real-time inputs that combined can generate incredible new insights about our health. Moreover, due to COVID-19, society has had to embrace telehealth and remote services as a new form of lifestyle and care procedure to reduce virus transmissions. What are these virtual care protocols, and new devices in the home designed to engage and communicate with us, monitor and measure our activity, to ultimately collect, organize and analyze? 

Here's who will be speaking: 

Uday Kumar founded  Element Science, where he also serves as President and CEO, in 2011. 

Kumar, a cardiologist and cardiac electrophysiologist by training, is the previously founded iRhythm Technologies, a digital healthcare company that used data analytics and machine leading to diagnose cardiac arrhythmias. He has also served as an Adjunct Clinical Instructor of Cardiovascular Medicine and Lecturer in Bioengineering at Stanford University, where he previously was a Biodesign Cardiovascular Innovation Fellow.

Kumar graduated from Harvard Medical School in June 1998. Prior to this, he received his B.A. magna cum laude in Biochemistry from Harvard College in 1994.

Element Science has developed a wearable patch defibrillator, which is initially targeted at treating the more than 500,000 patients in the US with an elevated temporary risk of potentially experiencing a lethal heart rhythm. The company has raised $183.1 million from investors that include Deerfield Healthcare,  Qiming Venture Partners USA, Cormorant Asset Management, Invus Opportunities, Third Rock Ventures and Google Ventures.

Sunny Kumar has been a Partner at GSR Ventures since 2017. He focuses on investments in early-stage companies applying artificial intelligence and machine learning technologies to the healthcare sector.

Prior to GSR Ventures, Kumar was an investor with the Stanford GSB Impact Fund, empowering high-impact healthcare startups, and he worked at Longitude Capital developing an investment thesis into gene and cell therapies.

Kumar received a BS in Molecular Biology from Yale University, an MD from Stanford University School of Medicine, and an MBA from Stanford University Graduate School of Business.

GSR Ventures, which was founded in 2004, focuses on artificial intelligence and digital health startups. The firm, which manages over $3 billion, has invested in companies such as Medable and Kinsa. 
 

Charles Jones was appointed CEO of MDLIVE in March, after serving as the company's chairman for more than three years. He is also the founder and managing partner of Bedford Funding, a healthcare technology-focused private equity firm with $1.4 billion in assets under management.

Jones was chief operating officer of London-based Shandwick plc, which during his tenure became the largest public relations firm in the world through acquisitions. Before this, he was chairman and CEOof Geac Computer Corp., a publicly listed business intelligence software company.

Founded in 2006, MDLIVE is a telehealth provider, which has over 40 million members nationwide. The company treats over 50 non-emergency conditions, including colds, allergies, and insect bites, while also providing behavioral health services and dermatology. MDLIVE has raised $123.6 million in venture funding from investors that include Heritage Group, Sutter Health, Kayne Anderson Capital Advisors, and former Apple CEO John Sculley.

Thanks to our sponsors: UCSF Health Hub, HPAvison YoungAdvsr Scrubbed, and Stratpoint.

Read more from our "The Future of Healthcare" series

More episodes

Related News